Inhibitor SourceBook™ Second Edition

More documents

Recommendations

Info

Index Ellipticine .................................................................................83 Ellipticine, 9-Hydroxy-, Hydrochloride ...........................80 Emetine, Dihydrochloride ................................................. 60 Emodin .....................................................................................49 Endothall .................................................................................60 (–)-Epigallocatechin Gallate .......................................7 , 80 Epirubicin Hydrochloride.....................................................83 Epoxomicin, Synthetic ...................................................... 37 InSolution Epoxomicin, Synthetic .............................. 39 Erbstatin Analog ....................................................................49 ERK Activation Inhibitor Peptide I, Cell-Permeable.....25 ERK Activation Inhibitor Peptide II, Cell-Permeable ...25 ERK Inhibitor ..........................................................................25 Erythromycin, Streptomyces erythreus ........................ 60 EST ................................................................................. 6, 29 ET- 8-OCH 3 ......................................................................3 , 93 Etazolate, Hydrochloride .................................................. 57 N-Ethylmaleimide .............................................................. 42 2-Ethyl-2-thiopseudourea, Hydrobromide .................. 0 Etoposide .................................................................................83 Etoposide Phosphate ............................................................83 ETYA ...................................................................................86, 92 Evodiamine, Evodia rutaecarpa ...................................... 54 F F 6 .......................................................................................... 5 FAAH Inhibitor I .....................................................................88 FAAH Inhibitor II....................................................................88 Fas/FasL Antagonist, Kp7-6................................................67 Fascaplysin, Synthetic .......................................................... 6 Fatty Acid Synthase Inhibitor, C75...................................88 Fenvalerate..............................................................................60 Flurbiprofen .....................................................................86, 96 Fluvastatin, Sodium Salt .....................................................89 FMS c Receptor Tyrosine Kinase Inhibitor (cFMS Receptor Tyrosine Kinase Inhibitor) ...........................48 Folimycin, Streptomyces sp. ........................................... 42 Fostriecin, Sodium Salt, Streptomyces pulveraceous .........................................60 FPT Inhibitor I ...................................................................... 44 FPT Inhibitor II ..................................................................... 45 FPT Inhibitor III ................................................................... 45 FR- ..........................................................................................70 FTase Inhibitor I .................................................................. 45 FTase Inhibitor II ................................................................. 45 FTase Inhibitor III................................................................ 45 FTI-276 .................................................................................. 45 FTI-277 .................................................................................. 45 FTI-2 48 ................................................................................ 45 FTI-2628 ............................................................................... 45 Fumonisin B , Fusarium moniliforme ...............................95 Furin Inhibitor I .................................................................... 8 Furin Inhibitor II .................................................................. 8 FUT- 75 ................................................................................ 29 G G 4 8 Sulfate, Cell Culture Tested ................................ 60 G 4 8 Sulfate, Sterile-Filtered Aqueous Solution, Cell Culture Tested ...................................................... 6 Galanthamine, Hydrobromide ...........................................98 InnoZyme Gelatinase Activity Assay Kit, Fluorogenic .................................................................... 22 Geldanamycin, Streptomyces hygroscopicus ......49, 49 Genistein ................................................................... 49, 83, 96 Genistin ....................................................................................49 Gentamycin Sulfate ..............................................................95 GGACK ................................................................................... 29 GGTI-286 .............................................................................. 45 GGTI-287 .............................................................................. 46 GGTI-297 .............................................................................. 46 GGTI-298 .............................................................................. 46 GGTI-2 33 ............................................................................ 46 GGTI-2 47 ............................................................................ 46 Gliotoxin, Gladiocladiumfimbriatum ................... 46, 54 H-Gly-Arg-Ala-Asp-Ser-Pro-OH ......................................70 H-Gly-Arg-Gly-Asp-Ser-OH ...............................................70 H-Gly-Arg-Gly-Asp-Ser-Pro-OH ......................................70 H-Gly-Arg-Gly-Asp-Thr-Pro-OH .......................................70 b-Glycerophosphate, Disodium Salt, Pentahydrate ....60 GM 489 ............................................................................... 20 GM 600 ............................................................................... 20 InSolution GM600 ........................................................ 20 GM 600 , Negative Control ............................................ 20 GNF-2 (Bcr-abl Inhibitor) ...................................................48 Gö 6976 ...................................................................................38 InSolution Gö 6976 ...........................................................38 Gö 6983 ...................................................................................38 Gö 7874, Hydrochloride ...............................................29, 38 Granzyme B Inhibitor I .................................................65, 66 Granzyme B Inhibitor II ................................................65, 66 Granzyme B Inhibitor IV ...............................................65, 66 Group III Caspase Inhibitor I ..............................................65 GSK-3b Inhibitor I ................................................................20 GSK-3b Inhibitor II ...............................................................20 GSK-3b Inhibitor III ..............................................................20 GSK-3b Inhibitor VI ..............................................................20 GSK-3b Inhibitor VII .............................................................20 GSK-3b Inhibitor VIII ...........................................................20 InSolution GSK-3b Inhibitor VIII ............................20, 84 GSK-3b Inhibitor XI ..............................................................20 GSK-3b Inhibitor XII, TWS 9 ...........................................20 GSK-3b Peptide Inhibitor ....................................................2 GSK-3b Peptide Inhibitor, Cell-permeable.....................2 GSK-3 Inhibitor IX.......................................................... 6, 20 InSolution GSK-3 Inhibitor IX .................................. 6, 20 GSK-3 Inhibitor X ..................................................................20 GSK-3 Inhibitor XIII ..............................................................20 GSK-3 Inhibitor XIV, Control, MeBIO ..............................20 GTP- 4564 ..............................................................................49 2-Guanidinoethylmercaptosuccinic Acid .................... 29 Guanosine 3´,5´-cyclic Monophosphorothioate, 8-(4-Choloro-phenylthio)-, Rp-Isomer, Triethylammonium Salt .................................................43 Guanosine 3´,5´-cyclic Monophosphorothioate, 8-Bromo-, Rp-Isomer, Sodium Salt ...........................43 Guanosine 3´,5´-cyclic Monophosphorothioate, b-Phenyl- , N2-etheno-8-bromo-, Rp-Isomer, Sodium Salt ......................................................................43 Guanosine 3´,5´-cyclic Monophosphorothioate, Rp-Isomer, Triethylammonium Salt ...........................43 H H-7, Dihydrochloride ............................................. 34, 38, 44 Iso-H-7, Dihydrochloride ....................................................38 H-8, Dihydrochloride ............................................................34 H-9, Dihydrochloride .....................................................34, 44 H-9, Immobilized...................................................................44 H-89, Dihydrochloride ............................................... 7, 9, 34 InSolution H-89, Dihydrochloride ............................9, 34 HA 004, Dihydrochloride.......................................7, 34, 44 HA 077, Dihydrochloride .................................... 34, 44, 56 Haloperidol ............................................................................ 0 HBDDE ......................................................................................38 Hdm2 E3 Ligase Inhibitor ................................................ 37 HDSF ...................................................................................... 29 Heat Shock Protein Inhibitor I ........................................ 49 Heat Shock Protein Inhibitor II ...................................... 49 Helenalin, A. chamissonis ssp. foliosa ........................... 54 Herbimycin A, Streptomyces sp. ........................................49 Hexokinase II VDAC Binding Domain Peptide, Cell-Permeable ............................................................. 5 Hinokitiol .................................................................................92 Hispidin ....................................................................................38 Histone Deacetylase Activity Assay Kit, Colorimetric ......................................................................75 Histone Deacetylase Activity Assay Kit, Fluorometric .....................................................................75 Histone Deacetylase HD2, Maize ......................................75 Histone Deacetylase Inhibitor I .........................................73 Histone Deacetylase Inhibitor II........................................74 Histone Deacetylase Inhibitor III ......................................74 N Histone Deacetylase, Human, Recombinant, S. frugiperda..........................................75 Histone Deacetylase, Rat Liver ..........................................75 HIV Protease Inhibitor ...................................................... 29 HNMPA-(AM) 3 ........................................................................49 Hsp25 Kinase Inhibitor ..............................................25, 49 Hsp27 ELISA Kit .................................................................. 49 HSV Replication Inhibitor, BP5 ..........................................72 Humanin, Human, Synthetic ..............................................67 (–)-Huperzine A, Huperzia serrata ...................................98 (±)-Huperzine A .....................................................................98 N G -Hydroxy-L-arginine, Monoacetate Salt ................ 04 N w -Hydroxy-nor-L-arginine, Diacetate Salt ............... 04 a-Hydroxyfarnesylphosphonic Acid ............................. 46 Hydroxyfasudil .......................................................................56 4-Hydroxynonenal ............................................................. 42 Hygromycin B, Streptomyces sp. .................................... 6 Hymenialdisine, Stylissa damicornis .................. 6, 2 , 26 Hypericin........................................................................... 0, 38 Hypocrellin B, Hypocrella bambusae ........................... 43 Hypoestoxide, Hypoestes rosea ...................................... 54 I IkB Kinase Inactive Control Peptide, Cell-Permeable ............................................................. 54 IkB Kinase Inhibitor Peptide, Cell-Permeable ............ 54 (±)-Ibuprofen ..........................................................................87 IC26 ........................................................................................ 0 ICG .............................................................................................2 IGF- R Inhibitor, PPP ...........................................................49 IKK Inhibitor II, Wedelolactone ...................................... 54 IKK Inhibitor III, BMS-34554 ........................................ 55 IKK-2 Inhibitor IV ............................................................... 55 IKK-2 Inhibitor V ................................................................ 55 IKK-2 Inhibitor VI ............................................................... 55 IKK-2 Inhibitor, SC-5 4 .................................................... 55 InSolution IKK-2 Inhibitor, SC-5 4 ............................ 55 L-N 5 -( -Iminoethyl)ornithine, Dihydrochloride .......... 0 Indirubin Derivative E804 ................................................... 7 Indirubin-3´-monoxime ............................................... 7, 2 Indirubin-3´-monoxime, 5-Iodo- .............................. 7, 2 Indirubin-3´-monoxime-5-sulphonic Acid ............. 7, 2 Indomethacin .........................................................................87 Indomethacin Amide, N-Octyl- .........................................87 Indomethacin Ester, 4-Methoxyphenyl- .........................87 Indomethacin Ester, n-Heptyl- ..........................................87 InnoZyme Gelatinase Activity Assay Kit, Fluorogenic .................................................................... 22 InnoZyme TACE Activity Kit ......................................... 03 InSolution AG 478 ...........................................................48 InSolution Akt Inhibitor IV ................................................4 InSolution Akt Inhibitor VIII, Isozyme-Selective, Akti- /2 ...............................................................................4 InSolution ALLN ...................................................... 5, 25 InSolution AMPK Inhibitor, Compound C ...............5, 84 InSolution AZT, Triphosphate,Tetralithium Salt .........80 InSolution BAY -7082 ................................................ 54 InSolution Bisindolylmaleimide I ...................................37 InSolution Blebbistatin, Racemic ................................ 42 InSolution Casein Kinase II Inhibitor, DMAT..........9, 84 InSolution Casein Kinase II Inhibitor I ...........................9 InSolution Casein Kinase I Inhibitor, D4476..........9, 84 InSolution Caspase-3 Inhibitor I, Cell-Permeable ....64 InSolution Caspase-3 Inhibitor II ..................................64 InSolution Caspase-8 Inhibitor II ...........................65, 66 InSolution Caspase-9 Inhibitor I ....................................65 InSolution Caspase Inhibitor I ........................................64 InSolution Caspase Inhibitor VI......................................64 InSolution Cycloheximide ............................................. 60 InSolution Epoxomicin, Synthetic .............................. 37 InSolution GM600 ........................................................ 20 InSolution Gö 6976 ...........................................................38 InSolution GSK-3 Inhibitor IX .................................. 6, 20 InSolution GSK-3b Inhibitor VIII ............................20, 84 InSolution H-89, Dihydrochloride ............................9, 34 InSolution IKK-2 Inhibitor, SC-5 4 ............................ 55 InSolution JAK Inhibitor I .........................................50, 84 InSolution JNK Inhibitor II ...............................................22 InSolution K-252a, Nocardiopsis sp. ................................... 7, 29, 34, 38, 44 InSolution KN-93 .................................................................7 InSolution KT5720 .............................................................34 InSolution Leptomycin A, Streptomyces sp. ...............76 InSolution Leptomycin B, Streptomyces sp. ...............76 InSolution LY 294002 .......................................................3 InSolution MANT-GppNHp ........................................... 40 InSolution MANT-GTPgS ............................................... 40 InSolution MG- 32 ........................................................ 37 68 Orders Phone 800 854 34 7 Calbiochem • Inhibitor SourceBook Fax 800 776 0999 Web www.emdbiosciences.com/calbiochem
InSolution Microcystin-LR, Microcystis aeruginosa.................................................60 InSolution ML 3 63 ...........................................................26 InSolution NF-kB Activation Inhibitor...................... 55 InSolution Okadaic Acid, Prorocentrum concavum ...............................................60 InSolution Olomoucine ..................................................... 7 InSolution OM99-2 ......................................................... 0 InSolution p38 MAP Kinase Inhibitor III ...............26, 84 InSolution PD 53035 ......................................................5 InSolution PD 58780 ......................................................84 InSolution PP2 ....................................................................5 InSolution Proteasome Inhibitor I .............................. 38 InSolution Q-VD-OPh, Non-O-methylated .................65 InSolution Raf Kinase Inhibitor I .................................55 InSolution Rapamycin .......................................................84 InSolution Ratjadone A, Synthetic ................................77 InSolution Rho Kinase Inhibitor ..............................56, 84 InSolution Ro-3 -8220 ....................................................40 InSolution Roscovitine ...................................................... 7 InSolution SB 202 90 .......................................................26 InSolution SB 203580 .......................................................27 InSolution g-Secretase Inhibitor IX ............................. 02 InSolution g-Secretase Inhibitor X .............................. 02 InSolution g-Secretase Inhibitor XIX ......................... 03 InSolution g-Secretase Inhibitor XVII ......................... 02 InSolution Sinefungin .......................................................7 InSolution Sirtinol ..............................................................74 InSolution Staurosporine, Streptomyces sp................35 InSolution SU6656.............................................................52 InSolution TAPI- ............................................................. 7 InSolution Tautomycetin, S. griseochromogenes ......62 InSolution Trichostatin A, Streptomyces sp................74 InSolution VEGF Receptor 2 Kinase Inhibitor III......53, 84 InSolution Y-27632 ...........................................................57 a-Iodoacetamide ............................................................... 29 5-Iodo-6-amino- ,2-benzopyrone ..................................79 5-Iodotubercidin ...................................................................26 I-OMe-AG 538 .......................................................................47 IP3K Inhibitor .........................................................................23 3-Isobutyl- -methylxanthine ......................................... 58 Isogranulatimide ................................................................... 2 Isohelenin, Inula sp. .......................................................... 55 ,5-Isoquinolinediol .............................................................79 Isotetrandrine .........................................................................93 ITSA .........................................................................................74 J JAK Inhibitor I ........................................................................50 InSolution JAK Inhibitor I .........................................50, 84 JAK2 Inhibitor II .....................................................................50 JAK3 Inhibitor I ......................................................................50 JAK3 Inhibitor II .....................................................................50 JAK3 Inhibitor III ...................................................................50 JAK3 Inhibitor IV ...................................................................50 JAK3 Inhibitor V .....................................................................50 JAK3 Inhibitor VI ...................................................................50 JAK3 Inhibitor, Negative Control ......................................50 Jervine ................................................................................... 62 JNK Inhibitor I, (L)-Form, Cell-Permeable ......................22 JNK Inhibitor I, (L)-Form, Cell-Permeable, Negative Control .............................................................22 JNK Inhibitor II .......................................................................22 InSolution JNK Inhibitor II ...............................................22 JNK Inhibitor II, Negative Control ....................................22 JNK Inhibitor III, Cell-Permeable ......................................22 JNK Inhibitor III, Cell-Permeable, Negative Control ....23 JNK Inhibitor V .......................................................................23 K K-252a, Nocardiopsis sp. ......................... 7, 29, 34, 38, 44 InSolution K-252a, Nocardiopsis sp. ................................... 7, 29, 34, 38, 44 K-252b, Nocardiopsis sp. .............................. 29, 34, 38, 44 K-252c ......................................................................................38 Kaempferol ..............................................................................87 Kanamycin Sulfate, Streptomyces kanamyceticus ... 6 Kanamycin Sulfate, Streptomyces kanamyceticus, Cell Culture-Tested ...................................................... 6 Calbiochem • Inhibitor SourceBook Kenpaullone ..................................................................... 7, 2 Ketoconazole ..........................................................................92 (Z-LL) 2 Ketone...................................................................... 29 Kifunensine, Kitasatosporia kifunense ......................... 48 Kininogen, High Molecular Weight, Single Chain, Human Plasma ................................... 30 Kininogen, High Molecular Weight, Two Chain, Human Plasma........................................ 30 Kininogen, Low Molecular Weight, Human Plasma .............................................................. 30 KN-62 .........................................................................................7 KN-92 .........................................................................................7 KN-93 .........................................................................................7 InSolution KN-93 .................................................................7 KN-93, Water-Soluble ...........................................................7 KT5720 .....................................................................................34 InSolution KT5720 .............................................................34 KT5823 .....................................................................................44 L L-744,832 ............................................................................. 46 Lactacystin, Synthetic ....................................................... 37 clasto-Lactacystin-b-lactone ........................................ 37 Lavendustin A .........................................................................50 Lavendustin B .........................................................................50 Lavendustin C ....................................................................8, 50 Lck Inhibitor ............................................................................50 InSolution Leptomycin A, Streptomyces sp. ...............78 InSolution Leptomycin B, Streptomyces sp. ...............78 Leuhistin ............................................................................... 30 Leupeptin, Hemisulfate .................................................... 30 LFM-A ...................................................................................50 LFM-A 2 ..................................................................................50 LFM-A 3 ..................................................................................50 Lipase Inhibitor, THL .............................................................90 Lipase Inhibitor, URB602, Monoacylglycerol (Monoacylglycerol Lipase Inhibitor, URB602) .........90 Lovastatin ................................................................................89 Lovastatin, Sodium Salt.......................................................89 Luteolin ................................................................................. 05 LY 83583 ............................................................................... 06 LY 294002 ...............................................................................3 InSolution LY 294002 .......................................................3 LY 3035 ................................................................................3 M a 2 -Macroglobulin, Human Plasma................................ 30 Mannostatin A, Hydrochloride ....................................... 48 InSolution MANT-GppNHp ........................................... 40 InSolution MANT-GTPgS ............................................... 40 Manumycin A, Streptomyces parvulus ..................95, 46 MAP Kinase Cascade Inhibitor Set ...................................28 MAP Kinase Inhibitor Set I .................................................28 MAP Kinase Inhibitor Set II ................................................28 Mastoparan .......................................................................... 43 MDL- 2,330A, Hydrochloride ......................................... 40 MEG, Hydrochloride............................................................ 0 MEK Inhibitor I .......................................................................26 MEK Inhibitor II .....................................................................26 MEK Inhibitor Set ..................................................................28 MEK /2 Inhibitor ...................................................................26 Melatonin .............................................................................. 0 Melittin ..........................................................................38, 40 Meloxicam ...............................................................................87 Merbarone ...............................................................................83 DL-2-Mercaptomethyl-3- guanidinoethylthiopropanoic Acid ......................... 30 Met Kinase Inhibitor ............................................................50 8-Methoxymethyl-3-isobutyl- -methylxanthine .... 58 Methyl Arachidonyl Fluorophosphonate ........................93 Methylene Blue ................................................................... 06 4-{[3´,4´-(Methylenedioxy)benzyl]amino} -6-methoxyquinazoline ............................................. 58 S-Methylisothiourea, Sulfate .......................................... 0 S-Methyl-L-thiocitrulline, Dihydrochloride ................. 0 a-Methylomuralide ........................................................... 37 Mevastatin ..............................................................................89 Mevastatin, Sodium Salt .....................................................89 MG- 5 ................................................................................ 37 Index MG- 32 ....................................................................... 0 , 37 InSolution MG- 32 ........................................................ 39 Microcystin-LF, Microcystis aeruginosa .........................60 Microcystin-LR, Microcystis aeruginosa .........................60 InSolution Microcystin-LR, Microcystis aeruginosa.................................................60 Microcystin-LW, Microcystis aeruginosa ........................60 Microcystin-RR, Microcystis aeruginosa ........................60 MIF Antagonist, ISO- ...................................................... 63 Milrinone .............................................................................. 58 Mitochondrial Permeability Transition Pore Reagents Set ........................................................ 52 MJ33 .........................................................................................94 MK-886 ....................................................................................92 MK2a Inhibitor .......................................................................26 InSolution ML 3 63 ...........................................................26 ML-7, Hydrochloride ............................................................29 ML-9, Hydrochloride ............................................................29 MMP Inhibitor I .................................................................. 20 MMP Inhibitor II ................................................................. 20 MMP Inhibitor III ................................................................ 20 MMP Inhibitor IV ................................................................ 20 MMP- ELISA Kit .............................................................. 22 MMP-2 ELISA Kit .............................................................. 22 MMP-2 Inhibitor I .............................................................. 20 MMP-2 Inhibitor II ............................................................ 20 MMP-2/MMP-3 Inhibitor I .............................................. 2 MMP-2/MMP-3 Inhibitor II ............................................ 2 MMP-2/MMP-9 Inhibitor I .............................................. 2 MMP-2/MMP-9 Inhibitor II ............................................ 2 MMP-2/MMP-9 Inhibitor III ........................................... 2 MMP-2/MMP-9 Inhibitor IV ........................................... 2 MMP-2/MMP-9 Inhibitor V ............................................ 2 MMP-3 ELISA Kit ............................................................... 22 MMP-3 Inhibitor I .............................................................. 2 MMP-3 Inhibitor II ............................................................ 2 MMP-3 Inhibitor III ........................................................... 2 MMP-3 Inhibitor IV ........................................................... 2 MMP-3 Inhibitor V ............................................................ 2 MMP-3 Inhibitor VI ........................................................... 2 MMP-3 Inhibitor VII .......................................................... 2 MMP-3 Inhibitor VIII ......................................................... 2 MMP-8 Inhibitor I .............................................................. 2 MMP-8 Inhibitor I, Negative Control ........................... 2 MMP-9 ELISA Kit .............................................................. 22 MMP-9 Inhibitor I .............................................................. 22 MMP-9/MMP- 3 Inhibitor I ........................................... 22 MMP-9/MMP- 3 Inhibitor II .......................................... 22 Active MMP- 3 ELISA Kit ................................................ 22 MMP- 3 Inhibitor .............................................................. 22 Monoacylglycerol Lipase Inhibitor, URB602 ..................90 N G -Monoethyl-L-arginine, Monoacetate Salt ............ 0 N G -Monomethyl-D-arginine, Monoacetate Salt ........ 0 N G -Monomethyl-L-arginine, Monoacetate Salt ......... mpV(pic) ...................................................................................60 MY-5445 ............................................................................... 58 Mycalolide B, Mycale sp. ................................................. 43 Myosin Light Chain Kinase Inhibitor Peptide 8 ..........29 N Naltrindole, Hydrochloride ...................................................5 a-Naphthyl Acid Phosphate, Monosodium Salt ..........60 NC- 300-B .......................................................................... 43 NDGA, Larrea divaricata ......................................................92 Necrosis Inhibitor, IM-54 ....................................................68 Necrostatin- .........................................................................68 Necrostatin- , Inactive Control ........................................68 NEMO-Binding Domain Binding Peptide, Cell-Permeable ............................................................. 55 NEMO-Binding Domain Binding Peptide, Cell-Permeable, Negative Control ........................... 55 Neomycin Sulfate ..................................................................94 Neomycin Sulfate, g-Irradiated, Tissue Culture Grade ......................................................94 NFAT Activation Inhibitor III ..............................................60 NF-kB Activation Inhibitor.............................................. 55 InSolution NF-kB Activation Inhibitor...................... 55 NF-kB SN50, Cell-Permeable Inhibitor Peptide ........ 56 NF-kB SN50M, Cell-Permeable Inactive Control Peptide ............................................................. 56 Technical Support Phone 800 628 8470 E-mail calbiochem@emdbiosciences.com 69
Page 1 and 2:
Inhibitor SourceBook Second Editio
Page 3 and 4:
Calbiochem • Inhibitor SourceBook
Page 5 and 6:
Page 7 and 8:
Akt (Protein Kinase B) Inhibitors,
Page 9 and 10:
Calmodulin-Dependent Protein Kinase
Page 11 and 12:
Casein Kinase (CK) Inhibitors Casei
Page 13 and 14:
Checkpoint Kinase Inhibitors Eukary
Page 15 and 16:
Cyclin-Dependent Kinase (Cdk) Inhib
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Glycogen Synthase Kinase-3 (GSK-3)
Page 23 and 24:
Glycogen Synthase Kinase Inhibitors
Page 25 and 26:
c-Jun N-Terminal Kinase (JNK/SAP Ki
Page 27 and 28:
Mitogen-Activated Protein (MAP) Kin
Page 29 and 30:
MAP Kinase Inhibitors, continued Ca
Page 31 and 32:
Myosin Light Chain Kinase (MLCK) In
Page 33 and 34:
Phosphatidylinositol 3-Kinase (PI 3
Page 35 and 36:
Page 37 and 38:
Protein Kinase A (PKA; cAMP-Depende
Page 39 and 40:
Isozyme Specificities of Selected P
Page 41 and 42:
Protein Kinase C (PKC) Inhibitors,
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Protein Tyrosine Kinase (PTK) Inhib
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Raf Kinase Inhibitors Raf kinases a
Page 59 and 60:
Rho Kinase (ROCK) Inhibitors, conti
Page 61 and 62:
Protein Phosphatase Inhibitors Calb
Page 63 and 64:
Protein Phosphatase Inhibitors, con
Page 65 and 66:
Apoptosis Caspase Inhibitors Activa
Page 67 and 68:
Caspase Inhibitors, continued Produ
Page 69 and 70:
Other Selected Inhibitors of Apopto
Page 71 and 72:
Page 73 and 74:
DNA Methyltransferase Inhibitors DN
Page 75 and 76:
Histone Acetylase and Deacetylase I
Page 77 and 78:
Related Products Histone Deacetylas
Page 79 and 80:
Nuclear Import/Export Inhibitors, c
Page 81 and 82:
Page 83 and 84:
Telomerase Inhibitors, continued Ca
Page 85 and 86:
Topoisomerase Related Inhibitors, c
Page 87 and 88:
Lipid Signaling Acetyl-CoA Carboxyl
Page 89 and 90:
Cyclooxygenase (COX) Inhibitors, co
Page 91 and 92:
HMG-CoA (3-Hydroxy-3-Methylglutaryl
Page 93 and 94:
Lipoxygenase (LOX) Inhibitors Lipox
Page 95 and 96:
Phospholipase Inhibitors Several si
Page 97 and 98:
Sphingomyelinase Inhibitors Ceramid
Page 99 and 100:
Amyloidogenesis Inhibitors Calbioch
Page 101 and 102:
Secretase Inhibitors Deposition of
Page 103 and 104:
Secretase Inhibitors Calbiochem •
Page 105 and 106:
Page 107 and 108:
Glutathione S-Transferase (GST) Inh
Page 109 and 110:
Guanylate Cyclase Inhibitors, conti
Page 111 and 112:
Characteristics of various forms of
Page 113 and 114:
Nitric Oxide Synthase (NOS) Inhibit
Page 115 and 116:
Proteases Anthrax Lethal Factor (LF
Page 117 and 118:
the ratio of active (76 kDa) to ina
Page 119 and 120: Collagenase Inhibitors (Also see Ma
Page 121 and 122: Matrix Metalloproteinase (MMP) Inhi
Page 123 and 124: Matrix Metalloproteinase Inhibitors
Page 125 and 126: Tissue Inhibitors of Matrix Metallo
Page 127 and 128: Protease Inhibitors The proper func
Page 129 and 130: Protease Inhibitors, continued Calb
Page 131 and 132: Protease Inhibitors, continued Calb
Page 133 and 134: Protease Inhibitors, continued Sele
Page 135 and 136: Protease Inhibitor Cocktails, conti
Page 137 and 138: N Animal-Free Protease Inhibitor Co
Page 139 and 140: Proteasome and Ubiquitination Pathw
Page 141 and 142: Transmembrane receptors of various
Page 143 and 144: Angiotensin-Converting Enzyme (ACE)
Page 145 and 146: ATPase Inhibitors, continued Calbio
Page 147 and 148: Calbiochem • Inhibitor SourceBook
Page 149 and 150: Inhibitors of Glycoprotein Processi
Page 151 and 152: Heat Shock Protein Inhibitors Heat
Page 153 and 154: Inhibitors of Mitochondrial Functio
Page 155 and 156: NF-kB Activation Inhibitors NF-kB,
Page 157 and 158: NF-kB Activation Inhibitors, contin
Page 159 and 160: Phosphodiesterase (PDE) Inhibitors
Page 161 and 162: Plasminogen Activator Inhibitors Ti
Page 163 and 164: Protein Synthesis Inhibitors, conti
Page 165 and 166: Sonic Hedgehog Signaling Inhibitors
Page 167 and 168: Why can’t I make serial dilutions
Page 169: Calpastatin, Human, Recombinant, Do
Page 173 and 174: RNA Polymerase III Inhibitor ......
Page 175 and 176: 324875 ............................
Page 177 and 178: Trademarks CALBIOCHEM®
Page 179 and 180: Your #1 Resource for Inhibitors! We
show all

Inhibitor SourceBook™ Second Edition

Create successful ePaper yourself

Delete template?

Save as template?